Micropapillary pattern in lung adenocarcinoma: Aspect on 18F-fluorodeoxyglucose positron emission tomography/computed tomography imaging

Interactive Cardiovascular and Thoracic Surgery

Volumn 10, Issue 1, 2010, Pages 144-145

  Prior, John O ^a   Stupp, Roger ^a   Christodoulou, Michel ^a   Letovanec, Igor ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

18F FDG; Micropapillary component; Non small cell lung cancer; PET CT; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ANTHRAX; ARTICLE; BRONCHOSCOPY; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DRUG UPTAKE; FEMALE; FOLLOW UP; HERBAL MEDICINE; HISTIOCYTOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG EMPHYSEMA; LUNG LAVAGE; LUNG LOBE; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; MICROSCOPY; PAPILLARY CARCINOMA; PLEURA FLUID; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; REPEAT PROCEDURE; TREATMENT REFUSAL;

ADENOCARCINOMA, PAPILLARY; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; NEOPLASM STAGING; PHYTOTHERAPY; PNEUMONECTOMY; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 74849130812     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1510/icvts.2009.213686     Document Type: Article

References (10)

1. Nassar H. Carcinomas with micropapillary morphology: clinical significance and current concepts. Adv Anat Pathol 2004;11:297-303.
2. Amin MB, Tamboli P, Merchant SH, Ordonez NG, Ro J, Ayala AG, Ro JY. Micropapillary component in lung adenocarcinoma: a distinctive histologic feature with possible prognostic significance. Am J Surg Pathol 2002;26:358-364.
3. Miyoshi T, Satoh Y, Okumura S, Nakagawa K, Shirakusa T, Tsuchiya E, Ishikawa Y. Early-stage lung adenocarcinomas with a micropapillary pattern, a distinct pathologic marker for a significantly poor prognosis. Am J Surg Pathol 2003;27:101-109.
4. Kuroda N, Hamaguchi N, Takeuchi E, Ohara M, Hirouchi T, Mizuno K. Lung adenocarcinoma with a micropapillary pattern: a clinicopathological study of 25 cases. APMIS 2006;114:381-385.
5. Gamez C, Rosell R, Fernandez A, Andia E, Arnaiz MD, Cardenal F, Lorenzo C. PET/CT fusion scan in lung cancer: current recommendations and innovations. J Thorac Oncol 2006;1:74-77.
6. Takamochi K, Yoshida J, Murakami K, Niho S, Ishii G, Nishimura M, Nishiwaki Y, Suzuki K, Nagai K. Pitfalls in lymph node staging with positron emission tomography in non-small cell lung cancer patients. Lung Cancer 2005;47:235-242.
7. Carnochan FM, Walker WS. Positron emission tomography may underestimate the extent of thoracic disease in lung cancer patients. Eur J Cardiothorac Surg 2009;35:781-784; discussion 784-785.
8. Hoshi R, Tsuzuku M, Horai T, Ishikawa Y, Satoh Y. Micropapillary clusters in early-stage lung adenocarcinomas: a distinct cytologic sign of significantly poor prognosis. Cancer 2004;102:81-86.
9. Nagano T, Ishii G, Nagai K, Ito T, Kawase A, Takahashi K, Nishimura Y, Nishiwaki Y, Ochiai A. Structural and biological properties of a papillary component generating a micropapillary component in lung adenocarcinoma. Lung Cancer 2009:doi: 10.1016/j.lungcan.2009.1004.1014.
10. Fischer BM, Olsen MW, Ley CD, Klausen TL, Mortensen J, Hojgaard L, Kristjansen PE. How few cancer cells can be detected by positron emission tomography? A frequent question addressed by an in vitro study. Eur J Nucl Med Mol Imaging 2006;33:697-702.